The Evidence Base
Video
VIDEO: Spotlight on Cencora at ISPOR Europe 2025
Ahead of ISPOR Europe 2025 (November 9–12, 2025, Glasgow, Scotland, UK) we caught up with Tommy Bramley, Senior Vice President, Global Consulting Services at Cencora, to hear about the company’s involvement in the conference. In this brief interview, Tommy discusses Cencora’s partnership with ISPOR, their planned sessions in Glasgow, and the ways they are working to improve patient access to innovation.
You can view the entire video or view a specific question by entering ‘Fullscreen’ or navigate via the ‘Visual Table of Contents’.
- 00:32: Cencora is an ISPOR Mission Partner and has spoken about its alignment with ISPOR’s Strategic Plan 2030. Could you explain what this partnership means in practice and how it reflects your role in supporting advances in HEOR and global health decision-making?
- 02:05: Cencora is hosting in several key sessions at ISPOR Europe this year. Which sessions would you highlight for attendees?
- 04:08: Looking beyond the meeting, how is Cencora working to help accelerate patient access to innovation through evidence generation and policy engagement?
Tommy Bramley
Senior Vice President, Global Consulting Services, Cencora
Tommy Bramley, PhD, is Senior Vice President, Global Consulting Services at Cencora, where he is responsible for delivery and expansion of global market access, real-world evidence, and health economics and outcomes research activities across international markets. Prior to this, he served as President of Lash Group and President of Xcenda, where he has dedicated his 20+ year career to enhancing the delivery and efficiency of healthcare to improve patient outcomes. Dr Bramley received his Bachelor of Science in Pharmacy from Drake University in 1997 and his Doctor of Philosophy in Pharmaceutical and Health Outcome Sciences from the University of South Carolina in 2001.
This Conference Sneak Peek has been developed through our media partnership with Cencora